Nexalin Technology, Inc. (NXLIW)
USD 0.29
(6.11%)
USD 0.29
(6.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 425.28 Thousand USD | -78.23% |
| 2022 | 1.95 Million USD | -19.8% |
| 2021 | 2.43 Million USD | 42.54% |
| 2020 | 1.7 Million USD | 32.27% |
| 2019 | 1.29 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 507.22 Thousand USD | 19.27% |
| 2024 Q2 | 212.1 Thousand USD | -58.18% |
| 2023 FY | 425.28 Thousand USD | -78.23% |
| 2023 Q2 | 1.18 Million USD | -1.07% |
| 2023 Q3 | 1.19 Million USD | 1.22% |
| 2023 Q1 | 1.19 Million USD | -38.8% |
| 2023 Q4 | 425.28 Thousand USD | -64.47% |
| 2022 Q2 | 2.79 Million USD | 6.11% |
| 2022 FY | 1.95 Million USD | -19.8% |
| 2022 Q1 | 2.63 Million USD | 8.21% |
| 2022 Q4 | 1.95 Million USD | -2.23% |
| 2022 Q3 | 1.99 Million USD | -28.56% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 2.43 Million USD | 42.54% |
| 2021 Q4 | 2.43 Million USD | 13.09% |
| 2021 Q3 | 2.15 Million USD | 3.04% |
| 2021 Q2 | 2.09 Million USD | 0.0% |
| 2020 Q4 | 1.7 Million USD | 0.0% |
| 2020 FY | 1.7 Million USD | 32.27% |
| 2019 FY | 1.29 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 99.224% |
| Axonics, Inc. | 82.35 Million USD | 99.484% |
| INVO Bioscience, Inc. | 19.99 Million USD | 97.873% |
| CVRx, Inc. | 39.28 Million USD | 98.917% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 99.809% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | 86.635% |
| MaxCyte, Inc. | 36.1 Million USD | 98.822% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 98.021% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 99.657% |
| Sintx Technologies, Inc. | 6.59 Million USD | 93.55% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 99.17% |
| Apyx Medical Corporation | 52.31 Million USD | 99.187% |
| Cutera, Inc. | 518.12 Million USD | 99.918% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 92.039% |
| NeuroPace, Inc. | 86.99 Million USD | 99.511% |
| IRIDEX Corporation | 24.91 Million USD | 98.293% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 99.516% |
| enVVeno Medical Corporation | 2.43 Million USD | 82.535% |
| TELA Bio, Inc. | 59.16 Million USD | 99.281% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.933% |
| UFP Technologies, Inc. | 118.04 Million USD | 99.64% |
| Modular Medical, Inc. | 2.27 Million USD | 81.282% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 98.55% |
| LENSAR, Inc. | 22.4 Million USD | 98.102% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.981% |
| Surmodics, Inc. | 65.82 Million USD | 99.354% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 95.879% |
| Inogen, Inc. | 121.38 Million USD | 99.65% |
| Tivic Health Systems, Inc. | 1.67 Million USD | 74.595% |
| RxSight, Inc. | 22.18 Million USD | 98.083% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 98.562% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 98.162% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | 0.0% |
| PetVivo Holdings, Inc. | 2.42 Million USD | 82.494% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 99.593% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.94% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 98.33% |
| Dynatronics Corporation | 11.78 Million USD | 96.39% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 99.177% |
| InMode Ltd. | 75.91 Million USD | 99.44% |
| Bruker Corporation | 2.83 Billion USD | 99.985% |
| Movano Inc. | 5.97 Million USD | 92.879% |
| Orthofix Medical Inc. | 326.58 Million USD | 99.87% |
| FONAR Corporation | 57.45 Million USD | 99.26% |
| BioSig Technologies, Inc. | 4.68 Million USD | 90.922% |
| Envoy Medical, Inc. | 9.4 Million USD | 95.477% |
| Align Technology, Inc. | 2.45 Billion USD | 99.983% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 99.271% |
| Talis Biomedical Corporation | 29.22 Million USD | 98.545% |
| Cerus Corporation | 144.3 Million USD | 99.705% |
| 908 Devices Inc. | 37.49 Million USD | 98.866% |
| Nemaura Medical Inc. | 26.37 Million USD | 98.388% |
| Outset Medical, Inc. | 190.91 Million USD | 99.777% |
| NanoVibronix, Inc. | 2.68 Million USD | 84.167% |
| Venus Concept Inc. | 107.1 Million USD | 99.603% |
| Telesis Bio, Inc. | 40.87 Million USD | 98.96% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 99.627% |
| Quipt Home Medical Corp. | 136.29 Million USD | 99.688% |
| IRadimed Corporation | 20.73 Million USD | 97.949% |
| Tenon Medical, Inc. | 5.56 Million USD | 92.361% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 88.094% |
| Pulmonx Corporation | 60.63 Million USD | 99.299% |
| iCAD, Inc. | 8 Million USD | 94.685% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 96.649% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | 76.986% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 98.957% |
| SI-BONE, Inc. | 61.05 Million USD | 99.303% |
| Semler Scientific, Inc. | 6.27 Million USD | 93.217% |
| Biotricity, Inc. | 35.91 Million USD | 98.816% |
| Cytosorbents Corporation | 29.98 Million USD | 98.582% |
| DexCom, Inc. | 4.19 Billion USD | 99.99% |
| ZimVie Inc. | 795.85 Million USD | 99.947% |
| Aethlon Medical, Inc. | 2.47 Million USD | 82.849% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 96.444% |
| IceCure Medical Ltd | 4.24 Million USD | 89.986% |
| PAVmed Inc | 57.13 Million USD | 99.256% |
| Sight Sciences, Inc. | 46.43 Million USD | 99.084% |
| Insulet Corporation | 1.85 Billion USD | 99.977% |
| Profound Medical Corp. | 12.66 Million USD | 96.642% |
| electroCore, Inc. | 8.94 Million USD | 95.246% |
| Bioventus Inc. | 589.79 Million USD | 99.928% |
| InspireMD, Inc. | 8.14 Million USD | 94.777% |
| PAVmed Inc. | 57.13 Million USD | 99.256% |
| Nuwellis, Inc. | 6.78 Million USD | 93.727% |
| OrthoPediatrics Corp. | 72.56 Million USD | 99.414% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 96.444% |
| BrainsWay Ltd. | 15.31 Million USD | 97.223% |
| BIOLASE, Inc. | 35.34 Million USD | 98.797% |
| Beyond Air, Inc. | 29.77 Million USD | 98.572% |
| AxoGen, Inc. | 101.16 Million USD | 99.58% |
| Inari Medical, Inc. | 209.32 Million USD | 99.797% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | 80.544% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | 76.094% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.987% |
| Quanterix Corporation | 78.08 Million USD | 99.455% |
| Viveve Medical, Inc. | 10.84 Million USD | 96.079% |
| LivaNova PLC | 1.15 Billion USD | 99.963% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 97.588% |
| Varex Imaging Corporation | 668.6 Million USD | 99.936% |
| Vivani Medical, Inc. | 25.03 Million USD | 98.301% |
| ReShape Lifesciences Inc. | 4.06 Million USD | 89.535% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 88.094% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 91.294% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.959% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.925% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 97.451% |
| NeuroMetrix, Inc. | 1.33 Million USD | 68.099% |
| Spectral AI, Inc. | 12.4 Million USD | 96.571% |
| Hyperfine, Inc. | 9.8 Million USD | 95.66% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 99.83% |
| Biomerica, Inc. | 2.66 Million USD | 84.03% |
| Bone Biologics Corporation | 831.4 Thousand USD | 48.848% |
| AVITA Medical, Inc. | 19.86 Million USD | 97.859% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | 78.452% |
| Silk Road Medical, Inc | 114.15 Million USD | 99.627% |